SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）

Name: SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）
License: Public Domain

CSPC Megalith Biopharmaceutical Co.,Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non

non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444863
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.